What is the address of DR. MARGOT ROMMENS - ANESTHESIST?

The registered office of DR. MARGOT ROMMENS - ANESTHESIST is located at Vijverstraat 4, 9030 Gent.

Is DR. MARGOT ROMMENS - ANESTHESIST still active?

Yes. According to the CBE (31 October 2026) DR. MARGOT ROMMENS - ANESTHESIST is active, legal situation “Normale toestand”, started on 26 December 2014.

Is DR. MARGOT ROMMENS - ANESTHESIST registered on Peppol?

Yes, DR. MARGOT ROMMENS - ANESTHESIST is registered on the Peppol network with ID 0208:0507773224.

What is the enterprise number of DR. MARGOT ROMMENS - ANESTHESIST?

The enterprise number of DR. MARGOT ROMMENS - ANESTHESIST is BE0507773224.

When was DR. MARGOT ROMMENS - ANESTHESIST founded?

DR. MARGOT ROMMENS - ANESTHESIST was founded on 26 December 2014.

Who are the directors of DR. MARGOT ROMMENS - ANESTHESIST?

According to the 2025 annual accounts, the directors of DR. MARGOT ROMMENS - ANESTHESIST are: Margot ROMMENS.

Is DR. MARGOT ROMMENS - ANESTHESIST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MARGOT ROMMENS - ANESTHESIST make in 2025?

DR. MARGOT ROMMENS - ANESTHESIST posted a profit after taxes of € 284,069 in financial year 2025.

What is the revenue of DR. MARGOT ROMMENS - ANESTHESIST?

As a small company, DR. MARGOT ROMMENS - ANESTHESIST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 378,623.

DR. MARGOT ROMMENS - ANESTHESIST (Private Limited) - Gent

Dossier DR. MARGOT ROMMENS - ANESTHESIST, printed on 1 November 2026 from databakkes.be/en/0507773224/dr-margot-rommens-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MARGOT ROMMENS - ANESTHESIST from Gent, company number BE0507773224, closed financial year 2025 with a result of € 284,069 after tax. For that financial year DR. MARGOT ROMMENS - ANESTHESIST recorded a gross margin of € 378,623 and equity of € 20,358. Compared with financial year 2024, the result moved from € 245,615 to € 284,069. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.

What it is worth Healthy

€ 20,358

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 284,069

▲ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 314,396

▲ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 284,069 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,121

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,021

▲ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,015

▲ 292% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 294,971 Gross margin 2022: € 294,971 First fiscal year in the series	€ 302,278 Gross margin 2023: € 302,278 ▲ 2% vs 2022 (€ 294,971) Favourable step	€ 347,267 Gross margin 2024: € 347,267 ▲ 15% vs 2023 (€ 302,278) Favourable step	€ 378,623 Gross margin 2025: € 378,623 ▲ 9% vs 2024 (€ 347,267) Favourable step	▲ 9%
Profit after taxes	€ 207,361 Profit after taxes 2022: € 207,361 First fiscal year in the series	€ 212,329 Profit after taxes 2023: € 212,329 ▲ 2% vs 2022 (€ 207,361) Favourable step	€ 245,615 Profit after taxes 2024: € 245,615 ▲ 16% vs 2023 (€ 212,329) Favourable step	€ 284,069 Profit after taxes 2025: € 284,069 ▲ 16% vs 2024 (€ 245,615) Favourable step	▲ 16%
Equity	€ 227,414 Equity 2022: € 227,414 First fiscal year in the series	€ 22,743 Equity 2023: € 22,743 ▼ 90% vs 2022 (€ 227,414) Unfavourable step	€ 20,358 Equity 2024: € 20,358 ▼ 10% vs 2023 (€ 22,743) Unfavourable step	€ 20,358 Equity 2025: € 20,358 Unchanged (€ 20,358) Unchanged
Total debts	€ 37,190 Total debts 2022: € 37,190 First fiscal year in the series	€ 234,958 Total debts 2023: € 234,958 ▲ € 197,768 vs 2022 (€ 37,190) Unfavourable step	€ 263,894 Total debts 2024: € 263,894 ▲ 12% vs 2023 (€ 234,958) Unfavourable step	€ 314,966 Total debts 2025: € 314,966 ▲ 19% vs 2024 (€ 263,894) Unfavourable step	▲ 19%
Cash	€ 199,215 Cash 2022: € 199,215 First fiscal year in the series	€ 215,518 Cash 2023: € 215,518 ▲ 8% vs 2022 (€ 199,215) Favourable step	€ 264,002 Cash 2024: € 264,002 ▲ 22% vs 2023 (€ 215,518) Favourable step	€ 314,396 Cash 2025: € 314,396 ▲ 19% vs 2024 (€ 264,002) Favourable step	▲ 19%
Land & buildings	€ 20,519 Land & buildings 2022: € 20,519 First fiscal year in the series	€ 17,335 Land & buildings 2023: € 17,335 ▼ 16% vs 2022 (€ 20,519) Unchanged	€ 14,152 Land & buildings 2024: € 14,152 ▼ 18% vs 2023 (€ 17,335) Unchanged	€ 11,986 Land & buildings 2025: € 11,986 ▼ 15% vs 2024 (€ 14,152) Unchanged	▼ 15%
Retained profit	€ 208,814 Retained profit 2022: € 208,814 First fiscal year in the series	€ 4,143 Retained profit 2023: € 4,143 ▼ 98% vs 2022 (€ 208,814) Unfavourable step	€ 1,758 Retained profit 2024: € 1,758 ▼ 58% vs 2023 (€ 4,143) Unfavourable step	€ 1,758 Retained profit 2025: € 1,758 Unchanged (€ 1,758) Unchanged
Dividend	€ 175,000 Dividend 2022: € 175,000 First fiscal year in the series	€ 417,000 Dividend 2023: € 417,000 ▲ 138% vs 2022 (€ 175,000) Unchanged	€ 248,000 Dividend 2024: € 248,000 ▼ 41% vs 2023 (€ 417,000) Unchanged	€ 284,069 Dividend 2025: € 284,069 ▲ 15% vs 2024 (€ 248,000) Unchanged	▲ 15%
Balance sheet total	€ 264,604 Balance sheet total 2022: € 264,604 First fiscal year in the series	€ 257,701 Balance sheet total 2023: € 257,701 ▼ 3% vs 2022 (€ 264,604) Unchanged	€ 284,252 Balance sheet total 2024: € 284,252 ▲ 10% vs 2023 (€ 257,701) Unchanged	€ 335,324 Balance sheet total 2025: € 335,324 ▲ 18% vs 2024 (€ 284,252) Unchanged	▲ 18%

Key figures of DR. MARGOT ROMMENS - ANESTHESIST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MARGOT ROMMENS - ANESTHESIST?

What happened at DR. MARGOT ROMMENS - ANESTHESIST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 15, 2026 New annual accounts for financial year 2025: profit of € 284,069 (▲ 16% vs 2024). Source: NBB ↗
Jan 1, 2015 New establishment in Gent. KBO
Dec 26, 2014 Start of the company according to the CBE. KBO

In short

From € 207,361 profit in 2022 to € 284,069 profit in 2025.

Paid € 296,857 in corporate taxes since 2022.

Best year ever: 2025, with € 284,069 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Margot ROMMENS

DR. MARGOT ROMMENS - ANESTHESIST

Behind DR. MARGOT ROMMENS - ANESTHESIST is Margot ROMMENS.

Directors

According to the 2025 annual accounts

Margot ROMMENS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Vijverstraat 4

9030 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0507.773.224
VAT number: BE 0507.773.224
Registered office: Vijverstraat 4, 9030 Gent
Names & denominations: DR. MARGOT ROMMENS - ANESTHESIST
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 December 2014
Peppol: Active · Active since 9 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗